HIV (GP120) FRAGMENT (315-329)(114991-28-5)
- Name: HIV (GP120) FRAGMENT (315-329)
- Synonyms:10: PN:WO0176643 SEQID: 9 claimed sequence; 10: PN: WO0226254 SEQID: 10 claimedprotein; 1244: PN: US20090175821 SEQID: 1521 claimed protein; 12: PN:WO2006083874 SEQID: 1 unclaimed sequence; 13: PN: US20020044948 SEQID: 15 unclaimedsequence; 13: PN: WO0057919 SEQID: 20 claimed sequence; 15: PN: US20080160089SEQID: 1 unclaimed sequence; 17: PN: US6749856 SEQID: 15 unclaimed sequence; 1:PN: US6180134 SEQID: 1 unclaimed sequence; 1: PN: WO2006055974 SEQID: 1unclaimed sequence; 1: PN: WO2007067744 SEQID: 1 unclaimed sequence; 1: PN:WO2008082719 SEQID: 1 claimed protein; 20: PN: US6210873 PAGE: 13 claimedprotein; 222: PN: WO0069900 SEQID: 1521 unclaimed sequence; 225: PN: WO0069900SEQID: 1524 unclaimed sequence; 2: PN: US20060188469 SEQID: 1 unclaimedsequence; 43: PN: US20060008448 SEQID: 43 unclaimed sequence; 61: PN: US7238711SEQID: 144 unclaimed sequence; 61: PN: WO0042071 FIGURE: 18 claimed protein; 6:PN: WO02094313 SEQID: 6 claimed sequence; 80: PN: US20090036653 SEQID: 81unclaimed protein; 8: PN: US6294322 SEQID: 7 unclaimed sequence; Glycoproteingp160env (315-329) (HIV-1 virus IIIB isolate); PN: US5981706 SEQID: 13 claimedprotein; gp120 V3 Loop fragment (human immunodeficiency virus-1 strain IIIbsynthetic)
- Molecular Formula:C73H126 N26 O18
- Molecular Weight:1655.97
- CAS Registry Number:114991-28-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 115025-90-6/3-(2-NAPHTHALEN-1-YL-ETHYL)-3-[2-(TETRAHYDRO-PYRAN-2-YL)-ETHYL]-PENTANEDIOIC ACID
- 115025-70-2/Spiro[bicyclo[3.1.0]hexane-6,2-oxirane], 3-(1-propenyl)- (9CI)
- 115023-79-5/Phenol, 2-amino-6-methyl-3-(1-methylethyl)- (9CI)
- 115025-68-8/Spiro[bicyclo[3.1.0]hexane-6,2-oxirane], 3-pentyl- (9CI)
- 115022-87-2/1-Azabicyclo[3.2.0]heptane-2,7-dione(9CI)
- 115016-99-4/(+)-Profenamine
- 115017-00-0/(-)-Profenamine
- 115013-50-8/FORMALDEHYDE, POLYMER WITH 2-ETHYLPHENOL, 3-METHYLPHENOL AND 4-METHYLPHENOL)
- 115012-46-9/1-(2-FLUORO-PHENYL)-PIPERIDIN-4-ONE
- 115012-14-1/5H-Pyrrolo[3,4-b]pyridin-5-one,7-amino-6,7-dihydro-(9CI)
- 115012-10-7/7H-Pyrrolo[3,4-b]pyridin-7-one,5,6-dihydro-5-hydroxy-(9CI)
- 115012-11-8/3-Pyridinecarboxamide,2-(hydroxymethyl)-(9CI)
- 115012-02-7/Carbamic acid, (4,5-dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)-, methyl ester (9CI)
- 115012-09-4/5H-Pyrrolo[3,4-b]pyridin-5-one,6,7-dihydro-7-hydroxy-(9CI)
- 115011-31-9/Urea, N-methyl-N-(5-methyl-2-benzothiazolyl)- (9CI)
- 115008-80-5/1-Aza-2-silacyclopentane, 1-cyclohexyl-2,2-dimethoxy-
- 115008-06-5/Pyrido[2,1-f]purine-2,4,6(1H,3H,7H)-trione, 8,9-dihydro-1,3,8,8-tetramethyl-
- 115005-78-2/4-Hydroxy Propofol 4-O-b-D-Glucuronide
- 114996-74-6/Ethanone, 1-[4-(fluoromethyl)phenyl]- (9CI)
- 114991-28-5/HIV (GP120) FRAGMENT (315-329)
- 114991-27-4/PROPOFOL-4-HYDROXY-4-HYDROGENSULFATE
- 114991-26-3/PROPOFOL GLUCURONIDE
- 114991-25-2/4-Hydroxy Propofol 1-O-b-D-Glucuronide
- 114983-43-6/Levulinohydroxamic acid (6CI)
- 114983-18-5/1,3-Dioxolo[4,5-h]quinazolin-6(7H)-one, 7-amino-8-methyl-
- 114981-11-2/1-Benzylimidazolidin-4-one
- 114980-57-3/6-Hepten-2-one, 5-methyl- (9CI)
- 114977-57-0/Pyridine,2-[(S)-methylsulfinyl]-(9CI)
- 114976-76-0/1,4-DIDEOXY-1,4-IMINO-D-MANNITOL HYDROCHLORIDE
- 114971-88-9/HEXA-4,5-DIENOIC ACID METHYL ESTER